BioTech Medics, Inc. to Penetrate $20 Billion Energy Drink Market by Initiating Facebook & Google Ad Campaign for BioBody Bal...
19 May 2012 - 12:19AM
Marketwired
BioTech Medics, Inc.(PINKSHEETS: BMCS) announced commencing an
Internet Advertising and Awareness Campaign on Facebook and Google.
BioBody Balance is a caffeine-free Energy Spray nutritional
supplement. BioTech's existing BioBody BalanceĀ® Concentrate
Supplement has sold over $5 million in gross sales. Now consumers
can enjoy the benefits of a new and improved BioBody's
non-carbonated BioBody Balance Energy Spray for purchase at
www.BioBodyBalance.com.
The initial BioBody Balance Facebook page is
www.Facebook.com/BioBodyBalance.
"Utilizing Facebook.com and Google as marketing partners is an
essential element to our advertising strategy and furthering the
product branding in the market place," commented Keith Houser, CEO
of Biotech Medics.
BIOBODY BALANCEĀ® is a unique supplement
with 10 years R&D. According to a California researcher
investigating USA health trends, one of the top five consumer
trends is for natural caffeine-free energy drinks. The U.S. energy
drink industry is anticipated to reach $19.7 billion in 2013.
BioBody Balance Energy Spray is a high quality pharmaceutical grade
vitamin energy supplement with over 14 vitamins, minerals, amino
acids with an aloe vera base for those who are concerned with
boosting energy, alertness and reducing general fatigue naturally
without artificial stimulants. BioBody Balance ingredients have
been clinically tested to demonstrate restoring natural energy,
strength, stamina and defenses.
BIOBODY BALANCEĀ® is superior because it is sprayed sublingually
'under your tongue.' Sublingual administration has advantages over
oral caffeine drinks because the product is absorbed faster.
BioBody Balance is more economical as the suggested retail price is
less than $.35 per serving compared to a caffeine energy drink at
$2.00 or more per serving.
Safe Harbor: Forward-Looking Statements This release contains
forward-looking statements within the meaning of The Private
Securities Litigation Reform Act of 1995 (the "Act"). In
Particular, in the preceding statements, the words "anticipated"
and similar conditional expressions are intended to identify
forward-looking statements within the meaning of the Act and are
subject to the safe harbor created by the Act. Such statements are
subject to certain risks, uncertainties and actual results could
differ materially from those expressed. The FDA has not evaluated
the BioBody Balance statements. BioBody Balance is not intended to
diagnose, treat or cure any disease.
Contact: Tom Wood Phone: 972-274-5533
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Dec 2024 to Jan 2025
BioTech Medics (PK) (USOTC:BMCS)
Historical Stock Chart
From Jan 2024 to Jan 2025
Real-Time news about BioTech Medics Inc (PK) (OTCMarkets): 0 recent articles
More BioTech Medics, Inc. News Articles